Cigarette smoking is a major risk factor for chronic obstructive pulmonary disease (COPD). Oxidative stress has been known for having a key role in pathogenesis of many diseases
Chronic obstructive pulmonary disease (COPD) is a complex multi-component condition whose clinical presentation is often complicated by co-morbidities and extrapulmonary clinical features. This presentation will…
Chronic Obstructive Pulmonary Disease causes significant morbidity and mortality worldwide. Most patients can be treated in primary care. However, even in patients with relatively mild airflow obstruction referral
cause fibrosis and thickening of the wall of small airway, all these increase the obstruction of small airway, reduce the air flow. The ongoing inflammation in small airway and lung
Chronic obstructive pulmonary disease (COPD) is an increasing health problem that affects about 600 million people globally, and it is expected to be the third most common cause of death
Rationale: Eosinophil inflammation in the airways is observed in some patients with chronic obstructive pulmonary disease (COPD) independent of asthma. However, little is known about not only mechanisms but also
recorded medical diagnosis; severity was grouped by GOLD criteria (Global Initiative for Chronic Obstructive Lung Disease). Emphysema was based on standard-dose CT scan; percentage quantification was determined through…
Nutritional abnormalities are often associated with Chronic Obstructive Pulmonary Disease (COPD). Their early detection is important, since they determine the patient's prognosis independently of the degree of lung…
Chronic obstructive pulmonary disease (COPD) is mainly characterized by airway mucus obstruction, chronic inflammation and emphysema. Identification of novel factors that control the COPD pulmonary phenotypes is an…
vicious circles between the two entities are established. Comorbidities in COPD-asthma, obesity and obstructive sleep apnea probably also involved in the control of asthma having the reflux material
generated in a diseased lung as well as information on airflow limitations due to obstructive illnesses should be available via a cough. Our target is to develop mathematical techniques
Chronic obstructive pulmonary disease(COPD)is a complex multifactorial illness involving both genetic and environmental factors and is one of the leading causes of death worldwide. Although considerable improvements have
stress are considered to be major pathophysiological hallmarks of severe lung diseases including chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF), but their role in the regulation of mucus…
Chronic obstructive pulmonary disease (COPD) is a major cause of disability, hospital admission and premature death in Australia. Estimates put the number of people affected at just over half
Smoking cigarettes is a major risk factor in the development and progression of chronic obstructive pulmonary disease (COPD). Potential Reduced Risk Products (RRPs*), are being developed to reduce smoking-related
they transfer their contents. COPD is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. The main pathological changes of COPD are emphysema and small airway remodeling
Chronic Obstructive Pulmonary Disease (COPD) is one of the most common respiratory ailments encountered by the physicians. This disease is a burden for both developed and developing countries ... study on COPD known as…
major systemic manifestation in patients with lung diseases, especially in those with chronic obstructive pulmonary disease (COPD). The difference between respiratory and limb muscle dysfunction needs to be made
Chronic obstructive pulmonary disease (COPD) is a respiratory disease characterized by progressive airflow limitation, with globally increasing prevalence. Although efforts to simplify COPD diagnosis to a single…
Chronic obstructive pulmonary disease (COPD) is considered a multidimensional disorder since, in addition to the lung disease, it also has important systemic manifestations and is associated with significant…
first phosphodiesterase 4 inhibitor approved in Europe to be used in severe chronic obstructive pulmonary disease (COPD). Its preclinical evaluation streamed its subsequent clinical development towards COPD based
BACKGROUND In 53 patients with non-obstructive renal disease, we compared the Doppler indices along with the corresponding histopathological findings. METHODS Patients were subjected to Doppler ultrasound before biopsy…